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Abstract:A prospective observational study was conducted at three ophthalmic clinics to assess the clinical 
patterns and etiology of uveitis in the Central Asia Republic of Tajikistan. All patients underwent physical and 
ophthalmologic examinations. Extensive efforts were made to determine the etiology of uveitis, including 
workups for Behçet's Disease (BD) and Vogt–Koyanagi–Harada (VKH) syndrome. All patients were tested for 
the presence of HLA-B27. Presence and/or history of tuberculosis and syphilis were ruled out. HSV, CMV, 
Chlamydia trachomatis and HIV antibody titers were determined by ELISA. Uveitis was diagnosed in 51 patient 
ages 14 to 60 were with women accounted for 60.8%. Bilateral uveitis was presented in 74.5% cases and 
dominated in all age groups. Seven HLA-B27-positive patients had isolated uveitis without systemic manifestations and five 
had uveitis associated with spondyloarthritis (SpA). In total, uveitis was associated most commonly with SpA (23.5%), BD (9.8%), 
and VKH syndrome (5.9%). In 41.2% of uveitis cases, etiology was unknown. Conclusions: The overall clinical patterns 
and etiology of uveitis in Tajikistan are comparable to those reported from outside the Central Asia region. 
Bilateral uveitis dominated in all age groups with HLA-B27-positive uveitis present in 23.5% of patients and 
more common in men. 
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I. Introduction
A broad group of ocular diseases and conditions linked to intraocular inflammation is commonly 
referred to as uveitis. The term uveitis covers inflammation of the uvea, which includes theiris, ciliary body, and 
choroid. Italso often includes inflammation of adjacent intraocular structures, suchas the retina (retinitis), 
optic disc (papillitis), and vitreous (vitritis)[1].Uveitis is a complex disease with environmental 
influences[2],some genetic predispositions[3],involvement of immune T and B cells, and cytokine and 
chemokine signaturesand signaling[4]. It is a potential cause of visual morbidity in the working age 
group[5, 6].Prolonged visual loss occurred in two-thirds of uveitis patients, with many patients meeting the 
criteria for legal blindness at some point in their follow-up. Older patients with bilateral inflammation and 
increasing duration of reduced vision are at the greatest risk of severe visual loss[7].Poorly controlled 
inflammation is often associated with the development of ocular complications[6].Uveitis is associated 
closely with a variety of systemic diseases and may be the first sign of those diseases, hence being a vital 
warning sign that allows early diagnosis and medical intervention[8].Inflammatory eye diseases often occur in 
conjunction with systemic inflammatory disorders, such as Behçet’s Disease (BD), sarcoidosis, human 
leukocyte antigen (HLA)-B27-associated disorders, and Vogt–Koyanagi–Harada (VKH) syndrome, often 
with different clinical phenotypes.Infectious uveitis was recently extensively reviewed[9, 10].Also, uveitis’s 
potential association with Zikavirus infection[11, 12] was added to a large group of infectious uveitis[13]. 
The combination of effects on sight, ocular discomfort, systemic disease, and treatment-related side 
effects often has a significant impact on the subject’s quality of life and deservesconsiderable attention. The 
worldwide prevalence of uveitis isestimated at 100-150/100,000 persons[8] and varies significantly by geographical region 
and country[7, 14].In the United States,the rate of noninfectious uveitis among adults was 121 cases per 100,000 persons[15].In a 
recent nationwide cohort study in South Korea, the annual incidence of uveitis ranged from 91 to 123/100,000[16].The 
socioeconomic impact of uveitis can be as significant as that of diabetic retinopathy and, in most cases, those 
affected are individuals of working age. Information on uveitis in the Central Asia region is notably absent from 
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recent reviews[14].The Republic of Tajikistan is a Central Asia country with a diverse landscape and climatic 
conditions ranging from desert to high-altitude mountains. The dominating ethnic group is Tajik (84.3%) with a 
large minority of Uzbek (12.2%), while other groups are Kyrgyz, Russian, Turkmen, and Tatar. In this article, 
we provide the initialanalysis of uveitis in the Republic of Tajikistan. 
II. Material and Methods
The current observational studywas conducted at theOphthalmic Department of the National Medical 
Center of the Republic of Tajikistan;the Department of Ophthalmology, Avicenna Tajik State Medical 
University; the ophthalmic patient care unit ofSogdiysk Oblast tertiary hospitalnamed afterKutfidinov, and the 
Eye Microsurgery Regional Centerin the city of Khujand.All procedures followed the tenets of the Declaration 
of Helsinki, and informed consent was obtained from all patients and the control group subjects. All patients 
underwent an ophthalmologic examination, as well as a general clinical examination. 
The ophthalmologic evaluation included visometry, biomicroscopy, ophthalmoscopy, tonometry, and 
autorefractometry,and was used to diagnose uveitis. The Standardization of Uveitis Nomenclature (SUN) Working Group 
recommendations[17, 18] were used in uveitis classification.During the period of 2011–2014,51 subjects were diagnosed 
with uveitis (Fig. 1).  
A      B 
Figure no 1:A. HLA-B27-negative bilateral chronic panuveitis associated with rheumatoidarthritis. Circular 
posterior synechiae, pigment on the anterior lens capsule.B. HLA-B27-positive acute anterior uveitis, not 
associated with SpA. Circularposterior synechiae, fibrin in the field of a pupil. 
Extensive efforts have been made to identify etiology of the disease[1].The general clinical 
examination of the patient included: a general examination by a therapist and a rheumatologist, a chest x-ray, an 
x-ray of the sinuses, according to indications, and computed tomography of the sacroiliac and peripheral
joints.Updated  International Criteria for Behçet's Disease were followed in diagnosingBD[19, 20]. The multisystem nature of 
VKH syndrome was taken into account during diagnosis based on the revised international criteria[21].The
control group included 50 subjects (20 men and 30 women) who did not have laboratory and clinical signs of
uveitis or articular syndrome at the time of the survey. All patients were tested for the presence of serum HLA-
B27.Presence and/or history of tuberculosis and syphilis were ruled out. To exclude other specific infections that
cause inflammation of the choroid, all patients undertook the determination serum antibody titerby ELISA to the
herpes simplex virus (HSV) and cytomegalovirus (CMV), Chlamydia trachomatis, and HIV. At the same time,
all patients underwent laboratory tests: a comprehensive metabolic panel, complete blood count with erythrocyte
sedimentation rate determination, urinalysis, determination of C-reactive protein,and serum rheumatoid factor.
Statistical data processing was performed using the software package STATISTICA 6.0 (StatSoft, Inc., 
USA). For absolute values, the mean values and the standard deviation (M±m) were calculated; for quality 
indicators, the relative value (p,%). Differences were considered statistically significant when p <0.05. 
III. Results
Fifty-one patients were diagnosed with uveitis during 2011–2014 at three leadingophthalmology 
centers in the Republic of Tajikistan.Women dominated among the uveitis patients (60.8%) while men 
constituted 39.2%. The subjects’ ages were between 14 and 60 years, with a narrower range in men, between 15 
and 49 years old,and a broader range in women, between 14 and 60 years old. Most patients (94.12%) with 
uveitis of various etiologies were under 50 years of age. More than 84% of patients with uveitis were people of 
working age from 19 to 60 years.Bilateral uveitis was identified in 38 subjects (74.5%) and unilateral uveitis 
was presented in 13 cases (25.5%). In men, unilateral uveitis was diagnosed in eight cases with the remaining 12 
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subjects having bilateral uveitis. In women, the difference was more dramatic, with 26 subjects showing 
bilateral uveitis and only five women having unilateral uveitis. Bilateral uveitis dominated all age groups (Table 
1).  
All subjects in the control group were HLA-B27-negative. Out of 51 patients, only 12 (23.5%) had 
HLA-B27-positive uveitis (Table 2). From this group, seven patients (13.7% of total) had isolated uveitis 
without systemic manifestations and five (9.8%) HLA-B27-positive patients had uveitis associated with 
spondyloarthritis(SpA) (Table 2). The HLA-B27-positive uveitiswas more common in men (seven) comparedto 





Number % Number % Number % 
Under 18 0 0.0 5 9.8 5 9.8 
19 - 30 6 11.8 13 25.5 19 37.3 
31 - 40 6 11.8 9 17.6 15 29.4 
41 - 50 1 1.9 8 15.7 9 17.6 
51 - 60 0 0.0 3 5.9 3 5.9 
Total 13 25.5 38 74.5 51 100 
women (five). In the remaining group of 39,the HLA-B27-negative patients, five patients were diagnosed with BD, three had VKH 
syndrome, two had viral uveitis, one had rheumatoid arthritis (RA), and 21 patients had uveitis origin undetermined.The HLA-B27-
negative uveitis waspresent in 26 women and 13 men. The most common was uveitis associated with SpA (12 subjects) and 
with BD (5 subjects). Bilateral uveitis was identified in nine (75%) out of 12 patients with SpA and in 28 (58.9%) of 39 patients 
with different etiology.  




Under 18 19‑ 30 31‑ 40 41‑ 50 51‑ 60 
HLA-B27-
positive uveitis 
Isolated 1 3 2 1 0 7 13.7 
Associated with SpA 0 2 2 1 0 5 9.8 
HLA-B27-
negative uveitis 
AssociatedwithSpA 1 1 4 0 1 7 13.7 
Associated with HSV or 
CMV 
0 1 1 0 0 2 3.9 
BD 0 5 0 0 0 5 9.8 
Associated with VKH 
syndrome 
0 1 2 0 0 3 5.9 
Associated with RA 0 1 0 0 0 1 2.0 
Unknown etiology 3 5 4 7 2 21 41.2 
Table no 3:The SUN Working Group Grading Scheme for Anterior Chamber Cells. 
Cells in 
anterior chamber 
HLA-B27 (+) uveitis 
n=12 




0 0 0 0 
0.5+ 0 0 0 
1+ 5 27 32 
2+ 4 7 11 
3+ 2 4 6 
4+ 1 1 1 
Table 3 describes the inflammation level based on the Working Group Grading Scheme for Anterior 
Chamber Cells[17, 18].Overall, in both HLA-B27-positive and HLA-B27-negative patients,grades 1+ and 2+ 
dominated. Grade 3+ was present in 17% and 10% of cases for HLA-B27-positive and HLA-B27-negative 
patients, respectively. Only one patient in each HLA-B27 group reacheda grade 4+anterior chamber cells level.  
Table no 4: The SUN Working Group Anatomic Classification of Uveitis. 
Uveitis Type Pathology Numberof cases 
Anterior Iridocyclitis 36 
Intermediate Posterior cyclitis 2 
Hyalitis 1 
Posterior Chorioretinitis 1 
Panuveitis Anterior chamber, vitreous and retina  10 
Anterior chamber, vitreous and choroid 1 
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Anatomically anterior uveitis dominated in the observed group, with 36 cases (71%) diagnosed as 
iridocyclitis. Eleven cases (22%) of panuveitis constituted the second largest group (Table 4). In the current 
study, we observed the duration of uveitis almost equallydistributed between sudden onset, recurrent, and 
chronic (Table 5). Sudden onset was observed in 75% of HLA-B27-positive uveitis cases and inallcases of 
HSV- or CMV-associated uveitis. Noticeably, all the cases of BD-associated uveitis had chronic manifestation 
(Table 5). All patients with VKH syndrome (100%) and patients with HLA-B27-negative uveitis associated with 
SpAin 85.7% of cases were women who had bilateral intraocular inflammation. 
Table no 5: Uveitis onset categories. 
Category 
Uveitis type and association 
HLA-B27-positive HLA-B27- negative 
Isolated SpA SpA HSV and CMV BD VKH RA Etiology Unknown Total 
Sudden 5 4 2 2 0 1 0 5 19 
Recurrent 2 1 2 0 0 2 0 9 16 
Chronic 0 0 3 0 5 0 1 7 16 
Total 7 5 7 2 5 3 1 21 51 
IV. Discussion
Our results provide the first glimpse ofuveitis in the geographically and ethnically diverse population of 
Tajikistan. This is a limited observational study confined to three centers and could be further limited by the 
attendance at centers by different population groups, especially in rural areas. Nevertheless, we were able to 
identify a variety of uveitis patients with different disease etiology.  
Age. Mean age for uveitis diagnoseswas 31.6±1.6, withmore than 84% of patients in the 19- to 60-year age 
range.This agrees well with the published data showing a very wide range of uveitis onset from ages 7 to 74. 
The average age based on the 42 reported cases in the recent review[14] was 36.8, with a minimum average 
reported at 24.9 for Hawaii and a maximum of 50.6 for Finland. Hence, similar to our study in Tajikistan, 
uveitis was most common in middle-aged patients. In a comparable Turkish population study, the mean age at 
uveitis presentation was 36.6±15.7 years, with the majority of patients (83.3%) in the 17- to 60-year age 
group[22].Guneyand co-authors[23] reported forthe Turkish population the mean age at the presentation at 
39.1±12.6.  
Gender. In our study,uveitis more often occurred in women (60.8%) compared to men (39.2%). In the U.S. 
population-based study, it was found that female gender isa positive risk factor for uveitis[2]. However,in 
Turkish population studies, uveitis was reported to be more common in men, 54% (1M:0.83F)[22].Several 
studies indicate that acute anterior uveitis is more prevalent in male patients[24].In a global analysis of uveitis 
epidemiology[14], out of 52 reported observationsin 20 (38.4%) cases, women had a high prevalence of uveitis. 
However, in the majority of cases (63.46%), the difference between male and female subjects was within 
the10% range.  
Unilateral and Bilateral Entities. Unilateral uveitis is reported to be either equally frequent or even more 
common compared with bilateral[14]. In Tajikistan, bilateral uveitis was identified in 38 subjects (74.5%) and 
unilateral uveitis was presented in only 13 cases (25.5%). In men, unilateral uveitis was diagnosed in eight 
cases, with the remaining 12 subjects having bilateral uveitis. In women, the difference was more dramatic, with 
26 subjects showing bilateral uveitis and only five women having unilateral uveitis. In our case, bilateral uveitis 
was dominating all age groups. 
HLA-B27. HLA-B27-positive anterior uveitis is the most commonly diagnosed form of anterior uveitis and 
represents the largest entity of noninfectious uveitis around the world, with HLA-B27-positiveanterior uveitis 
diagnosed in approximately 2–14% in large surveys, which included all patients with uveitis[25].A link between 
HLA-B27 and uveitis was initiallydescribed in 1973[26].Loh and Acharya[6]found that in HLA-B27-positive 
uveitis, poorly controlled inflammation was associated with the development of ocular complications, including 
vision loss. In a retrospective longitudinal cohort study with HLA-B27-positive uveitis seen at a tertiary care 
center,researchersfoundthat ocular hypertension (0.10/eyeyear) and posterior subcapsular cataracts 
(0.09/eyeyear) were the most common complications. Patients with chronic inflammation were also at greater 
risk of complications[6].Simultaneously, the prognosis for the visual outcome and complications of HLA-B27-
positive uveitis is rather favorable compared with HLA B27-negative patients, as <2% developed legal 
blindness and <5% visual impairment[25].Overall, about 50–75% of HLA-B27-positive patients with acute 
anterior uveitis have an associated spondyloarthropathy, with ankylosing spondylitis, reactive arthritis, and 
undifferentiated spondyloarthropathy the most common diagnoses[27].It was estimated that over a lifetime, a 
patient with ankylosing spondylitis has about a 50% chance of having at least one episode of uveitis, and HLA-
B27-positive patients who have uveitis usually have spondyloarthritis and frequently are unaware of this 
diagnosis[3].In Iran, out of 44 ankylosing spondylitis patients with acute anterior uveitis, 34 (77.27%) were 
HLA-B27-positive[28].In Tajikistan, the frequency of systemic disease associated with HLA-B27-positive 
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uveitis seems to be comparable to the frequency reported in Cuba (59%)[29], Korea ( 53 %)[30], and Italy 
(50%)[31]. 
In Tajikistan,41.67% of patients with HLA-B27-positive uveitis were associated with SpA. The exact 
mechanism by which HLA-B27 predisposes to systemic inflammatory conditions has been the subject of 
intensive research[32, 33]. HLA-B27 has a high degree of genetic polymorphism, with more than 220 alleles 
determined at DNA sequencing[34]. Some HLA-B27 subtypes have been associated with increased SpA 
risk[35],  although for the majority of subtypes, the physiological and biochemical significance and a role in the 
etiopathogenesis of the disease needs to be clarified. The prevalence of HLA-B27 varies widely between ethnic 
populations. HLA-B27positivity is virtually absent among sub-Saharan Africans, South American Indians, and 
Australian Aborigines. The highest prevalence—over 50%—is observed in the Pawaia tribe in Papua New 
Guinea and Haida natives of western Canada. The  prevalence of HLA-B27 is around 10% for many 
populations[27].Determined as part of the 2009 U.S. National Health and Nutrition Examination Survey data, 
the weighted, age-adjusted U.S.HLA–B27 prevalence was estimated at 6.1%, with a 1:1.12 male-to-female 
ratio[36].Tsiroukiet al.[14]summarized 38 studies with HLA–B27 results and reported a minimum of 0.2% in 
Japan and a maximum of 47% prevalence in Australia. An average relevance of HLA-B27-positive uveitis was 
8.6%. In our sample of the Tajik population, HLA-B27 was found in 12 out of 101 examined subjects 
(prevalence 11.88%), with the male-to-female ratio 1:0.71. This male-to-female ratio is very similar to 
1M:0.78F reported by Agnaniet al.[37]. However, Tripathiet al. report in theirstudy in Indore, India, anHLA-
B27-positive uveitis ratio of 1M:0.33F[38].In ananalysis of a decade of clinical records of 177 HLA-B27-
positive patients at the University Medical Center Utrecht, The Netherlands, Braakenburg and co-authors[39] 
also concluded that at the onset of acute anterior uveitis, the prevalence of HLA-B27–associated systemic 
disease was more frequent in males.  
VKHsyndrome. VKH syndrome is a multisystemic disorder characterized by bilateral granulomatous 
panuveitis with exudative retinal detachments from inflammation of the choroid. T-cell-mediatedautoimmune 
responses against antigenic components of melanocytes and melanocyte-associated antigens are thought to be 
the main driving forces of the disease[40]. In Tajikistan, VKH syndrome was diagnosed in 5.88% patients with 
uveitis. In a global analysis of publications from 1976 to 2015, an average of 5.74% was reported in 34 
publications that provided data for VKH and uveitis[14].The low frequency of 0.4% was reported for 
Turkey[41]and the high frequency of 22.4%for Thailand[42].However, at Siriraj Hospital, Mahidol University, 
Bangkok,Thailand, VKH was diagnosed in only 8.7% of cases. In Bangladesh, diagnoses of VKH were reported 
as 8.4%[43].VKH disease is more common as a cause of uveitis in Japan (frequency 7.0%) compared to the 
United States (frequency 1.5%)[44]. 
BD. BD is closely associated with uveitis and is characterized by a variety of treatment options and mixed 
outcome for visual impairment[45].BD is a multisystemic complex disorderwith unknown etiology and a 
distinct geographical distribution. The course of disease is characterized by exacerbationsand spontaneous 
remissions, and tends to be more active andsevere during the first years[20]. BD is a variable vessel vasculitis 
that follows a relapsing and remitting course. The heterogeneity in clinical manifestations that can include oral 
and genital ulcers, nodular and papulopustular lesions, peripheral arthritis, uveitis, arterial aneurysms, venous 
and arterial thrombosis, central nervous system involvement, and intestinal ulcers, can cause challenges in the 
diagnosis, management, and disease assessment of BD[45].BD is a major cause of noninfectious uveitis in many 
Asia-Pacific countries, ranging from 4% to 28% of uveitis cases[40].With a frequency of 3.9%,BD is more 
common as a cause of uveitis in Japan than in the United States (frequency 0.9%)[44].BD is one of the most 
common noninfectious etiologies in Turkish uveitis patients (24.9%)[22] and (6.6%)[23]as reported in separate 
studies. In a global epidemiology review, BD- associated uveitis was reported in 42 out of 56 reviewed 
publications[14] with an average of 8.24%. The maximum percentage was reported for Turkey (32.2%) and a 
minimum of 0.3% for India. In our observational study,five patients were diagnosed with BD, representing 9.8% 
of all cases, constituting one of the major uveitis associations with known etiology.  
HSV andCMV. Only two cases of infection-associated uveitis were registered in our study. Toxoplasmosis 
with 7.1% uveitis was common in Turkey[22], as well as HSV uveitis (6.0%)[22] and (13.3%)[23]as reported in 
separate studies. The association of uveitis with a variety of infections was recently extensively reviewed[9-13]. 
Unknown etiology. We report that 41.2% of cases of uveitis were of unknown etiology. Based on extensive 
analysis of publications from 1962 to 2009 in Medline database,Chamset al.[46]concluded that despite progress 
in laboratory techniques, imaging technology, and finding new causes for uveitis such as HTLV-1- and HLA-
dependent diseases, the frequency of uveitis with unknown etiology (idiopathic) is increasing.  
V. Conclusions
Fifty-one subjects aged 14-60 were diagnosed with predominantly bilateral uveitis in a prospective 
observational study at three leading ophthalmic clinics in Tajikistan. The overall clinical patterns and etiology of 
uveitis in Tajikistan are comparable to those reported from outside the Central Asia region. Women accounted 
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for 60.8% of uveitis patients. Bilateral uveitis dominated in all age groups with HLA-B27-positive uveitis 
present in 23.5% of patients and more common in men. In total, uveitis was associated most commonly with 
SpA(23.5%), BD (9.8%), and VKH syndrome (5.9%). In 41.2% of uveitis cases, etiology was unknown.  
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